DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zerit (Stavudine) - Adverse Event Reports - Hospitalization

 



Index of reports > Cases resulting in hospitalization (46)

     Neutropenia (8)Immune Reconstitution Syndrome (6)Herpes Zoster (6)Abdominal Pain (5)Vomiting (5)Rash (5)Cerebral Toxoplasmosis (5)Hypothyroidism (5)Pregnancy (5)Hypertriglyceridaemia (5)

Below is the selection of adverse event reports related to Zerit (Stavudine) that includes cases resulting in hospitalization.

 Reports 1 - 25 of 46   Next >>

Adverse event in 71 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22

Patient: 71 year old male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Neuropathy, Vitamin D Deficiency

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit

Videx



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-10-08

Patient: male

Adverse reactions / side effects: Nausea, Diabetes Mellitus, Diarrhoea, Hypertriglyceridaemia, Liver Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection CDC Group IV Subgroup E
    Start date: 1998-11-24

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-11-24

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-11-24

Other drugs received by patient: Diovan



Adverse event in 65 year old female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-26

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Stocrin Caps
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Epivir
    Dosage: interrupted on 17-apr-2006 restarted on 18-apr-2006 at 300mg daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Abacavir Sulfate



Adverse event in 65 year old female receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-07-24

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-18

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Simavastatin



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from France on 2007-07-24

Patient: 49 year old male

Adverse reactions / side effects: Weight Decreased, Pancreatitis Acute, Diabetes Mellitus, Polyuria, Lactic Acidosis, Pyrexia, Ketoacidosis, Constipation, Speech Disorder, Hypovolaemia, Polydipsia, Vomiting, Nausea, Blood Lactic Acid Increased, Ascites, Haemolysis, Cachexia, Haemoglobin Decreased, Renal Failure, Anorexia, Lipase Increased, Haptoglobin Increased, Asthenia, Sinus Tachycardia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Kivexa
    Dosage: 4tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-04-15
    End date: 2007-06-13

Kaletra
    Dosage: 1tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-04-15
    End date: 2007-06-13

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-10-01
    End date: 2006-12-09

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-04-01
    End date: 2006-12-09

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-04-01
    End date: 2006-12-09

Other drugs received by patient: Bactrim; Lipanthyl; Rivotril; Laroxyl



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-07-20

Patient: 49 year old male, weighing 52.0 kg (114.4 pounds)

Adverse reactions / side effects: Weight Decreased, Speech Disorder, Pancreatitis Acute, Vomiting, Nausea, Diabetes Mellitus, Lactic Acidosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-04-01
    End date: 2006-12-09

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-04-01
    End date: 2006-12-09

Kaletra
    Indication: HIV Infection
    Start date: 2007-04-15
    End date: 2007-06-13

Kivexa
    Indication: HIV Infection
    Start date: 2007-04-15
    End date: 2007-06-13

Viracept
    Indication: HIV Infection
    Start date: 1998-04-01
    End date: 2006-12-09

Other drugs received by patient: Bactrim; Lipanthyl; Rivotril; Laroxyl



Adverse event in 17 year old male receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from United Kingdom on 2007-07-17

Patient: 17 year old male

Adverse reactions / side effects: Hyperlipidaemia, Pancreatitis Haemorrhagic, Type 1 Diabetes Mellitus

Adverse event resulted in: hospitalization

Suspect drug(s):
Efavirenz
    Dosage: stopped 20-sep-2002 restarted 13-mar-2003.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-11-14

Videx
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-10-01
    End date: 2000-05-02

Zerit
    Dosage: stopped feb 17-1999, restarted 12-sep-1999
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1997-09-11
    End date: 2002-09-20

Zerit
    Dosage: stopped feb 17-1999, restarted 12-sep-1999
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-09-11
    End date: 2002-09-20

Invirase
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-09-02
    End date: 2000-11-13

Norvir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-09-02
    End date: 2000-11-13

Lamivudine
    Dosage: 01nov98 to unk;unk to 31oct1999 started 26jun2000 to 28jan2000, stopped 20sep2002; 27feb2003on
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1996-11-21
    End date: 1999-09-30

Other drugs received by patient: Loxonin; Selbex; Diflucan; Baktar; Factor IX Complex; Zidovudine; Camostat Mesylate



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from United States on 2007-07-06

Patient: 49 year old male

Adverse reactions / side effects: Hepatic Encephalopathy, Spinal Compression Fracture, Hepatic Failure, Cerebellar Haemorrhage, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Zerit
    Dosage: 80mg daily (06-sep-2001-04-jul-2004), dose decreased 60mg daily (05-jul-2004-01-feb-2005)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2005-02-01

Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2004-07-04

Stocrin Caps
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-11

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2004-12-06

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-07

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-07

Other drugs received by patient: Monilac; Recombinate; Octocog Alpha; Tenormin; Losartan Potassium; Adalat; Diovan; Nifedipine; Octocog Alpha; Valsartan; Lactulose



Adverse event in 50 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-06-26

Patient: 50 year old male

Adverse reactions / side effects: Drug Toxicity, Hepatic Encephalopathy, Hyperammonaemia, Lumbar Vertebral Fracture, Cerebellar Haemorrhage, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2005-02-01

Zerit
    Dosage: started on 06-sep-2001 at 80 mg then dosage decreased to 60 mg per day on 05-jul-2004.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2005-02-01

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2004-12-06

Other drugs received by patient: Recombinate; Monilac; Epivir; Stocrin; Viread



Adverse event in 35 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-26

Patient: 35 year old male

Adverse reactions / side effects: Hyperlipidaemia, Pseudomembranous Colitis, Lymphoma, Herpes Zoster

Adverse event resulted in: hospitalization

Suspect drug(s):
Efavirenz
    Dosage: interrupted 11/8/00, restarted 11/16/00.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-10-04
    End date: 2000-11-08

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-05-01
    End date: 1999-10-03

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-10-04
    End date: 2000-11-08

Norvir
    Dosage: 400 mg/bid 20jan99 to 3oct99, 200 mg/bid 9oct99 to 8nov00 then 400 mg/bid 16nov00 to cont.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1990-10-09
    End date: 2000-11-08

Ziagen
    Dosage: therapy interrupted 11/8/00, restarted 11/16/00
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-10-04
    End date: 2001-11-08

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1990-01-18
    End date: 2001-10-03

Prozei
    Dosage: therapy interrupted 11/8/00, restarted 11/16/00
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-10-04
    End date: 2001-11-08

Other drugs received by patient: Amikacin Sulfate; Ciprofloxacin; Allopurinol; Azithromycin; Ethambutol Hydrochloride; Metronidazole; Sulfamethoxazole and Trimethoprim; Clarithromycin; Polaramine; Crixivan



Adverse event in 39 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-21

Patient: 39 year old male

Adverse reactions / side effects: Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2005-04-24

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-04-24

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Other drugs received by patient: NEO-Minophagen C; Factor Viii; Kogenate



Adverse event in 37 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-06-18

Patient: 37 year old male

Adverse reactions / side effects: Neutropenia, Rash, Cerebral Toxoplasmosis, Herpes Zoster

Adverse event resulted in: hospitalization

Suspect drug(s):
Denosine IV
    Dosage: form reported as i.v. infusion.
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2005-03-11
    End date: 2005-03-29

Denosine IV
    Dosage: form reported as i.v. infusion.
    Start date: 2005-04-19
    End date: 2005-04-24

Valixa
    Administration route: Oral
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2005-04-25
    End date: 2005-05-17

Valixa
    Dosage: maintenance threrapy.
    Administration route: Oral
    Start date: 2005-05-18
    End date: 2005-07-21

Baktar
    Administration route: Oral
    Start date: 2005-03-12
    End date: 2005-04-06

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2005-05-06

Epivir
    Administration route: Oral
    Start date: 2005-06-10

Zerit
    Dosage: reported as zerit (sanilvudine).
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2005-05-06

Zerit
    Dosage: reported as zerit (sanilvudine).
    Administration route: Oral
    Start date: 2005-06-10
    End date: 2006-03-23

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2005-05-06

Kaletra
    Administration route: Oral
    Start date: 2005-06-10

Lectisol
    Dosage: reported as lectisol (diaphenylsulfone).
    Administration route: Oral
    Start date: 2005-06-23
    End date: 2005-06-28

Other drugs received by patient: Pentamidine Isethionate; Cortril; Diflucan; Fungizone; Zithromac; Pyrimethamine TAB; Clindamycin Hydrochloride; Calcium Folinate; Lenograstim; Prednisolone



Adverse event in female receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: female

Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: ongoing gestational weeks 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Videx
    Dosage: ongoing at gestational weeks 2 through 10
    Indication: HIV Infection
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: initiated at gestational week 10
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Retrovir
    Dosage: infusion at delivery
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Crixivan
    Dosage: ongoing gestational week 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Epivir
    Dosage: 6 week course after birth
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01



Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08

Patient: female

Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Zerit
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Crixivan
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: exposure began in week ten of gestation.
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Epivir
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Zidovudine
    Indication: HIV Infection
    Start date: 1997-01-01
    End date: 1997-01-01

Zidovudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Lamivudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01



Adverse event in 39 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-07

Patient: 39 year old male

Adverse reactions / side effects: Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2005-04-24

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-04-24

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Other drugs received by patient: NEO-Minophagen C; Factor Viii; Kogenate



Adverse event in 33 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-06-05

Patient: 33 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Rhinitis Allergic, Iron Deficiency Anaemia, Cytomegalovirus Viraemia, Upper Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Valixa
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2005-06-13

Valixa
    Dosage: indication: cytomegalovirus viraemia. drug maintained as of 31 march 2006.
    Administration route: Oral
    Start date: 2005-09-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2005-05-18

Epivir
    Administration route: Oral
    Start date: 2005-08-03

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2005-05-18

Zerit
    Administration route: Oral
    Start date: 2005-08-03

Other drugs received by patient: Stocrin; Diflucan; Truvada; Ketotifen



Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Zerit
    Dosage: exposure during gestation.

Videx
    Dosage: exposure during gestation.

Invirase
    Dosage: exposure during gestation.

Norvir
    Dosage: exposure during gestation.

Retrovir
    Dosage: exposure during delivery.
    Start date: 1999-07-02
    End date: 1999-07-02

Retrovir
    Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
    Indication: Prophylaxis
    Start date: 1999-07-02
    End date: 1999-08-10

Retrovir
    Administration route: Oral
    Start date: 1999-07-07
    End date: 1999-07-18

Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol



Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female

Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Zerit
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Crixivan
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: exposure began in week ten of gestation.
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Epivir
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Zidovudine
    Indication: HIV Infection
    Start date: 1997-01-01
    End date: 1997-01-01

Zidovudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Lamivudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01



Adverse event in 28 month old female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29

Patient: 28 month old female

Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Videx
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Retrovir
    Dosage: from the 13th week to the 26th week of gestation.
    Start date: 1997-10-01
    End date: 1998-01-01

Invirase
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Norvir
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: from the 17th week of gestation to the 26th week.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-11-01
    End date: 1998-01-01

Retrovir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-10-01
    End date: 1998-01-01



Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-25

Patient: female, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Flatulence, Mucous Stools, Platelet Count Increased, Hypercholesterolaemia, Hepatomegaly, Malaise, Obesity, Abdominal Distension, Hypertriglyceridaemia, Oxygen Saturation Decreased, Anaemia, Ventricular Tachycardia, Hypotonia, Neutropenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx
    Dosage: received from conception to day 3 of gestation, then from week 27 of gestation to delivery

Zerit

Sustiva

Invirase
    Dosage: initiated at 27 weeks of gestation
    Indication: HIV Infection

Norvir
    Dosage: received from week 27 of gestation to delivery

Fortovase
    Dosage: received from week 27 of gestation to delivery

Viramune
    Dosage: received one single oral dose, from 27 weeks gestation transplacental exposure
    Administration route: Oral
    Indication: HIV Infection

Viramune
    Dosage: received infusion during delivery,

Retrovir
    Dosage: received 6 weeks of antiretroviral therapy after delivery, 200mg/20ml

Retrovir
    Dosage: received from conception to day 3 of gestation and from week 27 of gestation to and at delivery.

Other drugs received by patient: Cordarone; Speciafoldine; Ferrostrane; Uvesterol D; Fluorex; AZT



Adverse event in 38 year old male receiving Zerit (Stavudine)

Reported by a physician from United States on 2007-05-18

Patient: 38 year old male

Adverse reactions / side effects: Abdominal Pain, Immune Reconstitution Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Prezista
    Administration route: Oral
    Indication: HIV Infection

Mk0518
    Administration route: Oral
    Indication: HIV Infection

Ritonavir
    Indication: HIV Infection

Ziagen
    Indication: HIV Infection

Truvada
    Indication: HIV Infection

Zerit
    Indication: HIV Infection

Other drugs received by patient: Valcyte; Bactrim DS; Zyvox



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from United States on 2007-05-02

Patient: 49 year old male

Adverse reactions / side effects: Hepatic Encephalopathy, Spinal Compression Fracture, Hepatic Failure, Cerebellar Haemorrhage, Fall, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Zerit
    Dosage: 80mg daily (06-sep-2001-04-jul-2004), dose decreased 60mg daily (05-jul-2004-01-feb-2005)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2005-02-01

Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2005-02-01

Stocrin Caps
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-11

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-09-06
    End date: 2004-12-06

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-07

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-07

Other drugs received by patient: Monilac; Recombinate; Octocog Alpha; Tenormin; Losartan Potassium; Adalat; Diovan; Nifedipine; Octocog Alpha; Valsartan; Lactulose



Adverse event in 37 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-04-26

Patient: 37 year old male

Adverse reactions / side effects: Dysgeusia, Liver Function Test Abnormal, General Physical Health Deterioration, Neutropenia, Infection

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-06
    End date: 2006-04-22

Epzicom
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-05-11

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-06
    End date: 2006-04-22

Zerit
    Dosage: 30mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-06
    End date: 2006-04-22

Baktar
    Administration route: Oral
    Indication: Pneumocystis Jiroveci Pneumonia
    Start date: 2006-03-23
    End date: 2006-04-27

Diflucan
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Oral Candidiasis
    Start date: 2006-04-13
    End date: 2006-05-10

Other drugs received by patient: Stocrin; Itraconazole; Gaster; Predonine; Myslee; Fungizone; Benambax



Adverse event in 65 year old female receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-04-23

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-18

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Takepron; Pentamidine Isethionate; Lipovas



Adverse event in 65 year old female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-19

Patient: 65 year old female

Adverse reactions / side effects: Hypothyroidism

Adverse event resulted in: hospitalization

Suspect drug(s):
Stocrin Caps
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Epivir
    Dosage: interrupted on 17-apr-2006 restarted on 18-apr-2006
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Abacavir Sulfate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-18

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Takepron; Pentamidine Isethionate



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009